Cardiac Shock Wave Therapy Improves Angina Symptoms

Ischemic threshold and QoL also improved in patients with chronic refractory angina pectoris

FRIDAY, March 30 (HealthDay News) -- Cardiac shock wave therapy (CSWT) can significantly improve symptoms, ischemic threshold during exercise, and specific quality-of-life parameters for patients with chronic refractory angina pectoris, according to a study published online March 23 in Cardiovascular Therapeutics.

To investigate whether CSWT can relieve the symptoms of chronic refractory angina pectoris, Jean-Paul Schmid, M.D., of the Bern University Hospital in Switzerland, and colleagues conducted a prospective, randomized, placebo-controlled study involving 21 patients with chronic refractory angina pectoris and evidence of inducible myocardial ischemia during MIBI single-photon emission computed tomography imaging. Eleven patients received nine sessions of CSWT (200 shots/spot, energy intensity of 0.09 mJ/mm²) over three months, and 10 controls received an acoustic simulation without energy application.

The researchers found that nine of 11 CSWT-treated patients experienced statistically significant symptom improvement, measured by cardiopulmonary exercise stress testing, compared with two of 10 placebo-treated patients. Physical functioning, general health perception, and vitality items on the Short Form-36 questionnaire were significantly improved in CSWT-treated patients, compared with no improvement in placebo-treated patients.

"This prospective, randomized study shows that CWST reduces clinical symptoms and objective signs of myocardial ischemia. CSWT therefore emerges as a new non-invasive technique for treatment of refractory angina pectoris in patients with advanced coronary artery disease," the authors write.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com